Investor
The pharma giant’s Digital Health Partnership Program welcomes new innovators in mental health, women’s health and more.
The life science company plans to launch its open research tool in 2022.
New NHS platform launched to address mental health crisis in young people.
The company is set to debut in the KOSDAQ early next year.
Lindera’s ‘SturzApp’ facilitates motion analysis via an app, using smartphone or tablet cameras to track movement and reduce the risk of falls in seniors.
Polish-based Docplanner steps up expansion plans in Germany.
The firm plans to further develop its blood typing technology.
The Series C brings its total raise to $160 million.
Funding will help take its DTx solutions through regulatory approvals and to market in the UK and US.
Global healthtech has received $51.3 billion in investment this year, marking new highs for venture capitalist interest in the sector and identifying London as the fastest growing healthtech hub globally.